Interferon–microRNA signalling drives liver precancerous lesion formation and hepatocarcinogenesis

Abstract

These findings demonstrate a new protumourigenic axis involving type I IFN-microRNA signalling, providing a potential therapeutic strategy to manipulate or reverse liver precancerous lesions and tumourigenesis.